Ravandi F, Cloos J, Buccisano F, Dillon R, et al. Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel. Am J Hematol 2023 Sep 6. doi: 10.1002/ajh.27087.
PMID: 37671649